These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 21679006

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways.
    Tans G, Curvers J, Middeldorp S, Thomassen MC, Meijers JC, Prins MH, Bouma BN, Büller HR, Rosing J.
    Thromb Haemost; 2000 Jul; 84(1):15-21. PubMed ID: 10928463
    [Abstract] [Full Text] [Related]

  • 24. Changes in blood levels of proteinase inhibitors, pregnancy zone protein, steroid carriers and complement factors induced by oral contraceptives.
    Nielsen CH, Poulsen HK, Teisner B, Thorsen P, Hau J, Westergaard JG.
    Eur J Obstet Gynecol Reprod Biol; 1993 Sep; 51(1):63-71. PubMed ID: 7506680
    [Abstract] [Full Text] [Related]

  • 25. Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol compared with one containing levonorgestrel and ethinylestradiol on haemostasis, lipids and carbohydrate metabolism.
    Ågren UM, Anttila M, Mäenpää-Liukko K, Rantala ML, Rautiainen H, Sommer WF, Mommers E.
    Eur J Contracept Reprod Health Care; 2011 Dec; 16(6):444-57. PubMed ID: 22066891
    [Abstract] [Full Text] [Related]

  • 26. Effect of second- and third-generation oral contraceptives on fibrinolysis in the absence or presence of the factor V Leiden mutation.
    Kemmeren JM, Algra A, Meijers JC, Bouma BN, Grobbee DE.
    Blood Coagul Fibrinolysis; 2002 Jul; 13(5):373-81. PubMed ID: 12138364
    [Abstract] [Full Text] [Related]

  • 27. The effects of a low-dose monophasic preparation of levonorgestrel and ethinyl estradiol on coagulation and other hemostatic factors.
    Archer DF, Mammen EF, Grubb GS.
    Am J Obstet Gynecol; 1999 Nov; 181(5 Pt 2):63-6. PubMed ID: 10561678
    [Abstract] [Full Text] [Related]

  • 28. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
    Notelovitz M, Kitchens CS, Khan FY.
    Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974
    [Abstract] [Full Text] [Related]

  • 29. Effects of a combined oral contraceptive containing oestradiol valerate/dienogest on hormone withdrawal-associated symptoms: results from the multicentre, randomised, double-blind, active-controlled HARMONY II study.
    Macìas G, Merki-Feld GS, Parke S, Mellinger U, Serrani M.
    J Obstet Gynaecol; 2013 Aug; 33(6):591-6. PubMed ID: 23919857
    [Abstract] [Full Text] [Related]

  • 30. Ethinylestradiol 20 versus 30 micrograms combined with 150 micrograms desogestrel: a large comparative study of the effects of two low-dose oral contraceptives on the hemostatic system.
    Winkler UH, Hölscher T, Schulte H, Zierleyn JP, Collet W, Schindler AE.
    Gynecol Endocrinol; 1996 Aug; 10(4):265-71. PubMed ID: 8908527
    [Abstract] [Full Text] [Related]

  • 31. Quadriphasic versus monophasic oral contraceptives for contraception.
    Van Vliet HA, Raps M, Lopez LM, Helmerhorst FM.
    Cochrane Database Syst Rev; 2011 Nov 09; (11):CD009038. PubMed ID: 22071862
    [Abstract] [Full Text] [Related]

  • 32. Effect of four different oral contraceptives on various sex hormones and serum-binding globulins.
    Wiegratz I, Kutschera E, Lee JH, Moore C, Mellinger U, Winkler UH, Kuhl H.
    Contraception; 2003 Jan 09; 67(1):25-32. PubMed ID: 12521654
    [Abstract] [Full Text] [Related]

  • 33. Estradiol valerate plus dienogest versus ethinylestradiol plus levonorgestrel for the treatment of primary dysmenorrhea.
    Petraglia F, Parke S, Serrani M, Mellinger U, Römer T.
    Int J Gynaecol Obstet; 2014 Jun 09; 125(3):270-4. PubMed ID: 24713413
    [Abstract] [Full Text] [Related]

  • 34. Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study.
    Dinger J, Assmann A, Möhner S, Minh TD.
    J Fam Plann Reprod Health Care; 2010 Jul 09; 36(3):123-9. PubMed ID: 20659364
    [Abstract] [Full Text] [Related]

  • 35. Combined oral contraceptives containing estradiol valerate vs ethinylestradiol on coagulation: A randomized clinical trial.
    Haverinen AH, Luiro KM, Szanto T, Kangasniemi MH, Hiltunen L, Sainio S, Piltonen TT, Lassila R, Tapanainen JS, Heikinheimo O.
    Acta Obstet Gynecol Scand; 2022 Oct 09; 101(10):1102-1111. PubMed ID: 35909329
    [Abstract] [Full Text] [Related]

  • 36. Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study.
    Rosing J, Middeldorp S, Curvers J, Christella M, Thomassen LG, Nicolaes GA, Meijers JC, Bouma BN, Büller HR, Prins MH, Tans G.
    Lancet; 1999 Dec 11; 354(9195):2036-40. PubMed ID: 10636369
    [Abstract] [Full Text] [Related]

  • 37. Effects of estradiol- and ethinylestradiol-based contraceptives on adrenal steroids: A randomized trial.
    Kangasniemi MH, Arffman RK, Haverinen A, Luiro K, Hustad S, Heikinheimo O, Tapanainen JS, Piltonen TT.
    Contraception; 2022 Dec 11; 116():59-65. PubMed ID: 36084710
    [Abstract] [Full Text] [Related]

  • 38. The effects of seven monophasic oral contraceptive regimens on hemostatic variables: conclusions from a large randomized multicenter study.
    Oral Contraceptive and Hemostasis Study Group.
    Contraception; 2003 Mar 11; 67(3):173-85. PubMed ID: 12618251
    [Abstract] [Full Text] [Related]

  • 39. Hormone withdrawal-associated symptoms: comparison of oestradiol valerate/dienogest versus ethinylestradiol/norgestimate.
    Jensen JT, Parke S, Mellinger U, Serrani M, Mabey RG.
    Eur J Contracept Reprod Health Care; 2013 Aug 11; 18(4):274-83. PubMed ID: 23638631
    [Abstract] [Full Text] [Related]

  • 40. The effect of oestrogen dose and progestogen type on haemostatic changes in women taking low dose oral contraceptives.
    Norris LA, Bonnar J.
    Br J Obstet Gynaecol; 1996 Mar 11; 103(3):261-7. PubMed ID: 8630312
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.